Analysts Stocks

      Ascendiant cuts SURG target to $3.5, stays Buy

      Ascendiant analyst Edward Woo trimmed their price target on SURG to $3.5 on June 10, keeping the rating at Buy.

      Edward’s record on SURG: 18 calls tracked, the stock touching the target in 1 of 18 of them.

      SURG carries 1 Buy ratings among the analysts AnaChart tracks. SURG last closed at $0.4.

      SURG price target chart: Ascendiant cuts to $3.5
      SURG price targets: Edward Woo against the highest and lowest current targets on the stock, plotted with the price.

      The $3.5 target is 775% above the stock’s $0.4 close.

      FAQ

      What is Ascendiant’s price target on SURG?

      Ascendiant’s Edward Woo has a $3.5 target on SURG, rated Buy, set June 10, 2026.

      How often have Edward Woo’s SURG price targets been reached?

      AnaChart has tracked 18 price-target calls from Edward Woo on SURG; the stock reached the target in 1 of them (6%).